Mandate

Vinge advises Intrum in connection with its EUR 450m bond issuance

Vinge advises Intrum AB (publ) in connection with its issuance of senior secured fixed rate bonds in an amount of EUR 450 million.

The proceeds will be used to refinance, in part, Intrum’s 3.125% Senior Notes due 2024, and the bonds will be listed on the Securities Official List of the Luxembourg Stock Exchange. The bonds have a tenor of five years and were issued with a coupon of 9.25 per cent and at a price of 97.020% of the nominal amount.

Vinge’s team consisted of Louise Brorsson Salomon, Lionardo Ojeda, Jolinn Uhlin, Calle Tengwall Pagels (Banking and Finance), Victor Ericsson and Maja Prahl (Tax)

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026